by Playfuls Staff |
16th February 2007

Lexington International LLC is proud to announce the
landmark achievement of US Food & Drug Administration (FDA) clearance for
their medical laser device, the HairMax LaserComb. [more] Through years of
extensive research and clinical studies in the science of hair growth,
Lexington has developed
an affordable and convenient, hand-held laser device, now clinically proven to
promote hair growth in males with androgenetic alopecia (Norwood IIA to V with
Fitzpatrick skin types I to IV).
This FDA clearance of the HairMax LaserComb offers an exciting
new modality for the promotion of hair growth in males. Until now, the FDA has
only approved two other products as solutions to combat hair loss, a condition
that affects approximately 55 million men in the U.S. But the HairMax LaserComb
stands out as the only proven drug-free alternative. This gives many hair loss
sufferers, previously unable or unwilling to turn to drug-based solutions,
newfound hope in their battle. Fortunately, treatments using the HairMax
LaserComb are easy to administer, only 10 to 15 minutes three times per week,
and the laser device is convenient to use in the comfort and privacy of your
own home.
For the FDA submission, Lexington
conducted an extensive clinical study in four different locations across the United States.
The study concluded that 93% of the participants (ages 30-60) using the HairMax
LaserComb had an increase in the number of terminal (thick) hairs. The average
number of terminal hairs per square centimeter increased by 19 hairs/cm - over
a six-month period. During the study, there were no reports of serious adverse
events. The number and types of adverse events were similar in both the active
and placebo groups.
Lexington’s
clinical study investigating the efficacy of the HairMax LaserComb in females
is concluding and they will be submitting the data to the FDA shortly.
David Michaels, Managing Director, shares his thoughts on
this momentous announcement, “We are very excited that we have reached a major
milestone in hair care and science. Laser hair therapy is the talk of the hair
restoration industry today. And not only were the results of this study
extremely significant, but with the credibility of the FDA clearance, we are
soundly positioned to make a substantial impact in the emerging hair
restoration industry.”
Dr. Matt Leavitt, Chief Medical Advisor to Lexington, expresses his enthusiasm on news
of the FDA clearance, “The HairMax LaserComb is a method of treatment that can
be of great help to men of all ages suffering from hair loss. I am impressed with
the protocol and results from the clinical trials that Lexington has conducted. With the FDA
clearing the HairMax LaserComb as a medical device, it offers an attractive
option for hair growth for medical practitioners. We can now deliver a new
modality to our patients and achieve strong user satisfaction.”
For over 20 years, the directors of Lexington have been at the forefront of laser
hair growth research. Born from this passion for innovation, The HairMax
LaserComb uses a patented technology to part the hair allowing the focused
laser energy to reach the scalp. The laser is most effective when it has an
unobstructed path directly to the hair follicle. Through extensive research, Lexington has determined
the optimal wavelength and energy level needed to deliver maximum results. Lexington’s continued
dedication to consistent innovation ensures that users are always receiving the
latest in laser hair technology.